Anders Kristoffersson, Ph.D.
Consultant

Bio
- Joined Pharmetheus in 2018, actively working in client projects.
- Expertise includes model informed drug development, pharmacometrics, and trial design for pharmacokinetic and pharmacokinetic-pharmacodynamic modelling.
- Experience as Postdoctoral Researcher at Uppsala University, Sweden, where he prepared mechanism based pharmacokinetic-pharmacodynamic models for selection of antibiotic dosing regimens supported by a grant from Hoffman-La Roche.
- M.Sc. in Molecular Biotechnology Engineering (2010) and Ph.D. in Pharmaceutical Biosciences (2015) from Uppsala University, Sweden.
Pharmetheus affiliated publications
A joint ketamine and esketamine exposure-response model of MADRS score in major depressive disorder to enable informed trial design for candidate drugs with similar mode of actionBounded integer model-based analysis of psoriasis area and severity index in patients with moderate-to-severe plaque psoriasis receiving BI 730357 treatmentBounded integer model-based analysis of psoriasis area and severity index in patients with moderate-to-severe plaque psoriasis receiving BI 730357Assessment of Expected Drug Exposure Relative Maximum Safety Limits in Early Phase Studies